We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

FTC Declines To Challenge Reverse Payment Deal

Law360 (March 20, 2009, 12:00 AM EDT) -- The Federal Trade Commission has disclosed that it will not challenge a so-called reverse payment agreement between generic-drug makers Mylan Inc., Dr. Reddy’s Laboratories Inc. and Cobalt Pharmaceuticals Inc. on one...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.